Anti-CTLA4 Monoclonal Antibody is named as a drug or biological intervention in 2 clinical trials in our China trial register, 1 of which is recruiting. The lead sponsor is Chinese PLA General Hospital. Registered phase: Phase 1. Conditions studied include Solid Tumor, Adult; EphA2 Overexpression; Lymphoma.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT05631886 | Combination of CAR-DC Vaccine and ICIs in Malignant Tumors (ClinicalTrials.gov ↗) Solid Tumor, Adult, Lymphoma, EphA2 Overexpression |
Phase 1 | Recruiting |
| NCT05631899 | CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors (ClinicalTrials.gov ↗) Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V |
Phase 1 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Solid Tumor, Adult | 2 |
| EphA2 Overexpression | 2 |
| Lymphoma | 1 |
| TP53 R273H | 1 |
| KRAS G12V | 1 |
| KRAS G12C | 1 |
| Lead sponsor | Trials |
|---|---|
| Chinese PLA General Hospital | 2 |
| Register | Anti-CTLA4 Monoclonal Antibody trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Anti-CTLA4 Monoclonal Antibody works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Anti-CTLA4 Monoclonal Antibody (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.